114 related articles for article (PubMed ID: 38857606)
1. Glutathione and acid dual-responsive bismuth-based nanosensitizer for chemo-mediated cancer sonodynamic therapy.
Chen G; Ping J; Du J; Zhao L; Li Y; Liu H
Biomed Mater; 2024 Jun; 19(4):. PubMed ID: 38857606
[TBL] [Abstract][Full Text] [Related]
2. Reactive Oxygen Species-Manipulated Drug Release from a Smart Envelope-Type Mesoporous Titanium Nanovehicle for Tumor Sonodynamic-Chemotherapy.
Shi J; Chen Z; Wang B; Wang L; Lu T; Zhang Z
ACS Appl Mater Interfaces; 2015 Dec; 7(51):28554-65. PubMed ID: 26587885
[TBL] [Abstract][Full Text] [Related]
3. Protoporphyrin-sensitized degradable bismuth nanoformulations for enhanced sonodynamic oncotherapy.
Song K; Chen G; He Z; Shen J; Ping J; Li Y; Zheng L; Miao Y; Zhang D
Acta Biomater; 2023 Mar; 158():637-648. PubMed ID: 36621634
[TBL] [Abstract][Full Text] [Related]
4. Reactive oxygen species and glutathione dual responsive nanoparticles for enhanced prostate cancer therapy.
Zhang L; Zhang S; Li M; Li Y; Xiong H; Jiang D; Li L; Huang H; Kang Y; Pang J
Mater Sci Eng C Mater Biol Appl; 2021 Apr; 123():111956. PubMed ID: 33812584
[TBL] [Abstract][Full Text] [Related]
5.
Kazemi M; Emami J; Hasanzadeh F; Minaiyan M; Mirian M; Lavasanifar A; Mokhtari M
Recent Pat Anticancer Drug Discov; 2020; 15(4):341-359. PubMed ID: 33023456
[TBL] [Abstract][Full Text] [Related]
6. Biodegradable Bismuth-Based Nano-Heterojunction for Enhanced Sonodynamic Oncotherapy through Charge Separation Engineering.
Song K; Du J; Wang X; Zheng L; Ouyang R; Li Y; Miao Y; Zhang D
Adv Healthc Mater; 2022 Jun; 11(11):e2102503. PubMed ID: 35114073
[TBL] [Abstract][Full Text] [Related]
7. Facile construction of bioreducible crosslinked polypeptide micelles for enhanced cancer combination therapy.
Ruttala HB; Chitrapriya N; Kaliraj K; Ramasamy T; Shin WH; Jeong JH; Kim JR; Ku SK; Choi HG; Yong CS; Kim JO
Acta Biomater; 2017 Nov; 63():135-149. PubMed ID: 28890258
[TBL] [Abstract][Full Text] [Related]
8. Co-delivery of Docetaxel and Disulfonate Tetraphenyl Chlorin in One Nanoparticle Produces Strong Synergism between Chemo- and Photodynamic Therapy in Drug-Sensitive and -Resistant Cancer Cells.
Gaio E; Conte C; Esposito D; Miotto G; Quaglia F; Moret F; Reddi E
Mol Pharm; 2018 Oct; 15(10):4599-4611. PubMed ID: 30148955
[TBL] [Abstract][Full Text] [Related]
9. Manganese porphyrin-based metal-organic framework for synergistic sonodynamic therapy and ferroptosis in hypoxic tumors.
Xu Q; Zhan G; Zhang Z; Yong T; Yang X; Gan L
Theranostics; 2021; 11(4):1937-1952. PubMed ID: 33408790
[TBL] [Abstract][Full Text] [Related]
10. Selective Intratumoral Drug Release and Simultaneous Inhibition of Oxidative Stress by a Highly Reductive Nanosystem and Its Application as an Anti-tumor Agent.
Zhu C; Luo L; Jiang X; Jiang M; Luo Z; Li X; Qiu W; Jin Z; Shen T; Li C; Li Q; Qiu Y; You J
Theranostics; 2020; 10(3):1166-1180. PubMed ID: 31938058
[TBL] [Abstract][Full Text] [Related]
11. Enzymatic multifunctional biodegradable polymers for pH- and ROS-responsive anticancer drug delivery.
Su M; Xiao S; Shu M; Lu Y; Zeng Q; Xie J; Jiang Z; Liu J
Colloids Surf B Biointerfaces; 2020 Sep; 193():111067. PubMed ID: 32388121
[TBL] [Abstract][Full Text] [Related]
12. Synergistic chemo-photothermal cancer therapy of pH-responsive polymeric nanoparticles loaded IR825 and DTX with charge-reversal property.
Wang X; Gu Y; Li Q; Xu Y; Shi Y; Wang Z; Xia M; Li J; Wang D
Colloids Surf B Biointerfaces; 2022 Jan; 209(Pt 2):112164. PubMed ID: 34735859
[TBL] [Abstract][Full Text] [Related]
13. Core-matched nanoassemblies for targeted co-delivery of chemotherapy and photosensitizer to treat drug-resistant cancer.
Jiang D; Xu M; Pei Y; Huang Y; Chen Y; Ma F; Lu H; Chen J
Acta Biomater; 2019 Apr; 88():406-421. PubMed ID: 30763634
[TBL] [Abstract][Full Text] [Related]
14. A sonosensitiser-based polymeric nanoplatform for chemo-sonodynamic combination therapy of lung cancer.
Zhang Y; Khan AR; Yang X; Shi Y; Zhao X; Zhai G
J Nanobiotechnology; 2021 Feb; 19(1):57. PubMed ID: 33632266
[TBL] [Abstract][Full Text] [Related]
15. Optimization of Docetaxel Loading Conditions in Liposomes: proposing potential products for metastatic breast carcinoma chemotherapy.
Vakili-Ghartavol R; Rezayat SM; Faridi-Majidi R; Sadri K; Jaafari MR
Sci Rep; 2020 Mar; 10(1):5569. PubMed ID: 32221371
[TBL] [Abstract][Full Text] [Related]
16. DTX@VTX NPs synergy PD-L1 immune checkpoint nanoinhibitor to reshape immunosuppressive tumor microenvironment for enhancing chemo-immunotherapy.
Zhang R; Wan Y; Lv H; Li F; Lee CS
J Mater Chem B; 2021 Sep; 9(36):7544-7556. PubMed ID: 34551052
[TBL] [Abstract][Full Text] [Related]
17. Novel T7-Modified pH-Responsive Targeted Nanosystem for Co-Delivery of Docetaxel and Curcumin in the Treatment of Esophageal Cancer.
Deng L; Zhu X; Yu Z; Li Y; Qin L; Liu Z; Feng L; Guo R; Zheng Y
Int J Nanomedicine; 2020; 15():7745-7762. PubMed ID: 33116498
[TBL] [Abstract][Full Text] [Related]
18. Laser-Induced Transformable BiS@HSA/DTX Multiple Nanorods for Photoacoustic/Computed Tomography Dual-Modal Imaging Guided Photothermal/Chemo Combinatorial Anticancer Therapy.
Guo W; Chen J; Liu L; Eltahan AS; Rosato N; Yu J; Wang D; Chen J; Bottini M; Liang XJ
ACS Appl Mater Interfaces; 2018 Dec; 10(48):41167-41177. PubMed ID: 30406646
[TBL] [Abstract][Full Text] [Related]
19. Facile Synthesis of a Multifunctional Porous Organic Polymer Nanosonosensitizer (mHM@HMME) for Enhanced Cancer Sonodynamic Therapy.
Li M; Liu Z; Tang J; Cheng L; Xue Y; Liu Y; Liu J
ACS Appl Mater Interfaces; 2024 Jun; 16(22):28104-28117. PubMed ID: 38769350
[TBL] [Abstract][Full Text] [Related]
20. Redox-responsive nanoparticles based on Chondroitin Sulfate and Docetaxel prodrug for tumor targeted delivery of Docetaxel.
Li Y; Chen X; Ji J; Li L; Zhai G
Carbohydr Polym; 2021 Mar; 255():117393. PubMed ID: 33436222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
